Clinical Research: Establishing a Comprehensive Database for Home Parenteral Nutrition: Six Years of Data by Jones, Katherine R. et al.
Clinical Research 
Establishing a Comprehensive Database for Home Parenteral 
Nutrition: Six Years of Data 
Katherine R. Jones, RN, PhD, FAAN*; Debra S. Kovacevich, RN, MPH, CNSNf; and 
Daniel H. Teitelbaum, MD$ 
*University of Colorado School of Nursing, Denver, fUniversity of Michigan Health System, and $University of 
Michigan Medical School, Ann Arbor, Michigan 
ABSTRACT: Documenting the outcomes of therapy is 
mandatory in  today's health care environment. Such 
information is required by external agencies and desired 
by internal users. This article describes the development 
of a comprehensive database by one home infusion service 
that allows benchmarking of the results of care with other 
services over time. It also can be used to identify problems 
that are suitable for quality improvement initiatives. The 
database additionally allows analyses of the relationship 
between changing patient demographics and treatment 
processes over time and selected outcomes. Given the high 
cost and growing number of patients receiving home 
infusion services, the ability to address these kinds of 
questions is imperative for individual providers and for 
the entire health system. 
Documenting the outcomes of therapies and 
interventions has become mandatory in today's 
health care environment. Regulatory agencies, pur- 
chasers of services, and potential or actual custom- 
ers are all demanding information about the results 
achieved by the providers of care. At the University 
of Michigan Health System, a database has been 
created that allows the measurement of demo- 
graphic, treatment process, and outcome variables 
associated with the delivery of selected home infu- 
sion services. Such a database allows the bench- 
marking of processes and outcomes of care with 
other providers, and the trending of outcomes, pro- 
cesses, and patient characteristics over time. 
Home parenteral nutrition (HPN) represents a 
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complex treatment modality. Patients are referred 
for therapy when they are unable to maintain ade- 
quate nutrition. Patients present with a variety of 
primary and secondary diagnoses, are usually 
chronically ill, and span the age range. They may 
experience complications during the period of infu- 
sion therapy as a result of their underlying disease 
process, the therapeutic process, or both. Duration 
of therapy may last from a few days to a few years. 
The majority of patients receiving HPN could be 
classified as high cost patients. 
This paper describes the development and utili- 
zation of a comprehensive database for HPN 
patients that can serve as a standard for bench- 
marking our processes and outcomes of care. The 
results of 6 years of HPN patient care services are 
presented, and examples of the kinds of additional 
analyses that can be conducted using such a data- 
base. 
Background 
Many issues have been identified in connection 
with the delivery of parenteral nutrition in the 
home. Psycho-social concerns have included frustra- 
tion over the inability to eat,' altered body image,2 
social ~ t i g m a , ~  social barriers to chronic 
dependence on a caregiver: and financial b ~ r d e n . ~  
Physiologic complications in HPN therapy include 
fluid and electrolyte imbalances, glucose imbal- 
ances, catheter sepsis and catheter-related mechan- 
ical problems,6 and fatigue.7 System-related issues 
have involved inadequate discharge planning, insuf- 
ficiently trained homecare staff, and lack of clinical 
 guideline^.^,^ Resource utilization issues include 
repeated hospital admissions and visits to  the emer- 
gency department. 
In spite of these issues, the delivery of home 
parenteral nutrition and other infusion services has 
grown at a rapid pace. An estimated 18,000 atients 
received HPN in 1986 and 39,000 in 1992. It has 
been estimated that the number of HPN patients is 
growing at a rate of 25% per year." HPN is being 
used in the management of new diseases, such as 
AIDS, and for the more typical metabolic and neo- 
279 
280 JONES ET AL Vol. 15, No. 6 
plastic conditions. When assessing the success of 
home infusion services, the outcomes measured are 
usually mortality and longevity, complications of 
therapy, extent of rehabilitation as judged by the 
provider, and hospitalization.” Less frequently 
studied are outcomes such as quality of life and 
caregiver distress. 
In 1995, the Joint Commission on Accreditation of 
Healthcare Organizations (JCAHO) introduced spe- 
cific nutrition care standards for hospitalized 
patients, which included mandatory interdiscipli- 
nary care planning and effectiveness monitoring of 
nutrition care support.12 These were followed by 
ORYX, which required the systematic collection of 
data on a limited number of outcome variables using 
standardized methods. These requirements, along 
with other Report Card initiatives and quality 
improvement activities taking place within health 
care organizations, have convinced providers that 
they must invest in database development to enable 
them to respond to inquiries about care processes 
and outcomes. 
Materials and Methods 
The database is drawn from patients receiving 
home infusion services from a university hospital- 
affiliated home infusion company in the Midwest. 
Patients are usually referred for home infusion 
services from the inpatient setting, with the referral 
process arranged by discharge coordinators. A team 
of hospital-based nurses performs an initial assess- 
ment of the patient and the designated primary 
caregiver, and begins the training process. Patients 
may receive all, some, or none of their training in the 
inpatient setting. If training is incomplete before 
discharge, it is continued by home health nurses. 
Data were abstracted from the medical records of 
most HPN patients completing therapy between 
January 1993 and December 1998. The database 
does not include patients who chose or who were 
directed to receive their home infusion services from 
a different infusion care provider. It also excludes 
patients who began their therapy before the estab- 
lishment of the current home infusion company or 
whose medical records were missing large amounts 
of data. Data abstraction forms were developed by 
the first two authors (K.J., D.K.), tested, and refined. 
Face and content validity were established by an 
expert panel, which consisted of two nurses from the 
HPN team; a dietitian from the home enteral nutri- 
tion therapy team; a pharmacist from the home 
medical infusion team; a home health nurse experi- 
enced with home infusion therapy; the medical 
director; a service manager; and a nurse researcher. 
Written guidelines were developed to ensure data 
abstraction reliability and to help train new data 
collectors. A code book was developed to guide the 
coding and computer entry of the abstracted data. 
Because of the complexity and length of many of the 
medical records, all were abstracted twice, and the 
results compared by the principal investigator. All 
data inconsistencies were resolved by the HPN 
nurse manager. 
Data categories include patient demographics; 
primary and secondary diagnoses; reason for home 
infusion therapy; nutritional status; treatment pro- 
cesses including type of infusion pump and IV cath- 
eter; and outcomes including catheter sepsis, hospi- 
talizations, system problems, and final disposition. 
Data were entered into a Microsoft ACCESS data- 
base program, and analyses were done using SAS for 
the personal computer. Simple descriptive statistics 
were used for the analyses in this paper. 
Results 
Demographics 
Figure 1 shows the demographic characteristics 
of the patients cared for by the service and dis- 
charged over the past six years. The number of 
individuals discharged annually from the service 
nearly doubled over the time period, reflecting the 
increasing popularity of home-based therapies. The 
mean age of the patients was 33.6 years (+22.9), 
with an age range extending from one month to 78 
years. There were slightly more females (53%) than 
males (47%) in the predominantly white (90%) pop- 
ulation. The majority of patients were either mar- 
ried (46%) or under the age of 18 (34%). The most 
frequent source of payment was Blue CrosslBlue 
Shield (41%), reflecting the service’s’ Midwest loca- 
tion. Most patients lived with their spouses (49%) or 
their parents (42%). The usual primary caregiver 
was a family member (76%), although 23% of the 
charts identified the patient as the primary care- 
giver. 
Figure 2 shows the distribution of primary diag- 
noses among patients in our sample. The primary 
diagnoses were distributed primarily across solid 
(26%) and blood (14%) neoplasms and various gas- 
trointestinal conditions, although there was a fairly 
large number of other diagnoses, including AIDS, 
hyperemesis associated with pregnancy, and end- 
stage renal disease. Figure 3 shows that the two 
most common final dispositions from therapy were 
resumption of oral intake (52%) and death (21%). 
Some patients (6%) transferred to other infusion 
providers, primarily because of insurance company 
decisions. A few patients were removed from ther- 
apy due to non-compliance (5%) or other issues, 
whereas a few other patients withdrew from therapy 
(3%), due primarily to quality of life concerns. The 
majority of patients who died while on therapy had 
cancer listed as the primary cause of death. Only 
four patients died from sepsis, which can be a 
complication of the treatment process. 
Treatment Chorucferisfics 
Table 1 shows the primary treatment process 
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Figure 1. Patient demographic characteristics. 
patient underwent one course of home parenteral 
nutrition therapy, although almost 10% of the 
patients received more than one course of therapy. 
Patients missed on average more than two weeks of 
home therapy due to hospital admissions. Thus the 
average patient was on HPN for just over 100 days, 
receiving about 87 days of therapy in the home and 
the rest in the hospital. There was one, predomi- 
nant, ambulatory electronic infusion pump (CADD- 
total parenteral nutrition [TPN]) used in the early 
years and a different pump (AIM) brought into use 
in the later years. The most commonly used infusion 
catheters were peripherally inserted central cathe- 
ters (PICCs; 50%) and tunneled catheters (Hick- 
mans and Broviacs; 44%). Initial catheters were 











Figure 2. Primary diagnoses. 
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Figure 3. Final disposition from therapy. 
(27%), the patient died (15%), or the patient developed 
a catheter sepsis (11%). Catheters were also removed 
for a myriad of other reasons, including leaking, occlu- 
sion, being pulled or falling out, exit site infection, line 
migration, and ruling out sepsis. About two-thirds of 
the patients needed one infusion catheter for their 
course of therapy. The mean number of days for all IV 
catheters was 164 (2187) days per patient. Most of the 
patients had either a gauze and tape (43%) or trans- 
parent (53%) dressing over their catheters. The fre- 
quency of catheter dressing changes vaned substan- 
tially across patients, ranging from once a day (19%) to 
once a week (4%). The most common schedules were 
two (35%) or three (19%) days a week. The individual 
doing the catheter dressing change also vaned across 
patients. Home health nurses (53%) were most fre- 
quently responsible for the dressing change, but fam- 
ily caregivers also changed a large percentage (40%) of 
the dressings. 
Patients received an average of 5.1 (23.4) hours of 
home infusion training by the nurse before discharge 
from the hospital. The range in training hours was 0 to 
28, although this latter figure represented an outlier, 
and the next highest number of training hours was 14. 
Some patients required no hospital training because 
they had received home infusion therapy previously, 
or were to receive all training from the home health 
nurse after discharge. Spouses (32%) and parents 
(38%) of patients were most oRen involved with the 
training, although a broad range of individuals and 
pairs of relatives were also involved. About one-third 
of the caregivers experienced problems during their 
training, most often feeling averwhelmed by the pro- 
cess and the amount of information to be learned. 
Many caregivers required reinforcement of specific 
aspects of the instruction. 
Outcomes 
Table 2 and Figure 4 display the patient outcomes 
monitored within the database. Clinical outcomes of 
interest included the incidence of catheter sepsis, 
non-catheter infections, and symptomatology. Cath- 
eter sepsis episodes had to be confirmed by a positive 
culture that identified a specific microorganism. A 
new catheter sepsis was identified only if more than 
three weeks had elapsed from a previous diagnosis, 
or if there was a new line in place or a new organism 
cultured. Non-catheter-related infections included 
documented urinary tract infections and wound 
infections. Symptoms were recorded whenever 
patients or their caregivers reported problems such 
as nausea, diarrhea, itching, pain, and fever. Utili- 
zation outcomes included number of hospital admis- 
sions, number of hospital days, number of emer- . 
gency room visits, and the reasons for hospital 
admission and emergency care. Treatment-related 
outcomes include catheter problems (mechanical 
problems with the catheter), tubing problems (prob- 
lems with the tubing such as air or blood backups), 
pump, delivery and supply problems, satisfaction 
with care and services, and educatiodtraining needs 
postdischarge. Psychosocial and economic problems 
that were identified by the patient, caregiver, or 
home health nurse were also recorded. These 
included reported difficulty coping with the disease 
or treatment process, depression, anger, family con- 
flicts, and loss of electricity or telephone service. 
. 
Outcome Summary 
Twenty-seven percent of the entire sample expe- 
rienced a t  least one episode of catheter sepsis, with 
a range of one to nine sepsis episodes per infected 
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Table 1 
Treatment process characteristics 
Variable N % (Mean] 
Courses of therapy-mean 326 1.12 (k0.5) 
Total days at homemean 326 86.5 (2130.4) 
Total days on servicemean 326 104.1 (2146.7) 
Infusion pump 
CADD/TPN 117 36.1 % 
AIM 206 63.6% 
Other 1 0.3% 
Gauze/tape 137 43.1 % 
Transparent 168 52.8% 
Other 8 2.5% 
Daily 62 19.4% 
Every 3 days 62 19.4% 
2/week 1 1 1  34.7% 
3/week 60 18.8% 
1 /week 12 3.8% 
Other 13 4.1% 
Family caregiver 128 40.0% 
Patient 18 5.6% 
Other 3 0.9% 
Nurse 249 5.1 hrs 23.4) 
Pharmacist 249 0.8 hrs 121.8) 
None 37 14.5% 
Spouse 81 3 1.6% 
Parent 96 37.5% 
Son/Daughter 13 5.1% 
Other 29 11.6% 
None 171 67.3% 
Overwhelmed 37 14.6% 
Needed reinforcement 18 7.1% 
Other 25 10.0% 
PlCC 163 50.0% 
Tunneled 142 43.5% 
Other 21 6.5% 
Completed therapy 83 25.6% 
Patient death 48 14.8% 
. Leaking 23 7.1% 
Occlusion 7 2.2% 
Pulled/fell out 8 2.5% 
Thrombosis 5 1.5% 
Phlebitis 5 1.5% 
Discontinued treatment 9 2.8% 
Line migration 8 2.5% 
Exit site infection 8 2.5% 
Catheter malfunction 3 0.9% 
Cellulitis 3 0.9% 
Other 6 1.9% 
Catheter dressing 
Dressing change frequency 
Dressing changed by: 
Agency 171 53.4% 
Predischarge training hours-mean 
Caregiver involvement in training 
Learning difficulties documented 
Type of catheter-initial 
Reason for initial catheter removal 
Catheter sepsis 37 11.4% 
R/O sepsis 14 4.3% 
Catheter tear, rip 6 1.9% 
Total catheters-mean 315 1.6 (2.93) 
Total catheter days-mean 257 164.2 (2  186.9) 
PlCC = Peripherally Inserted Central Catheter. 
Number in parentheses is standard deviation. 
n = number of subjects. 
Table 2 
Patient outcome variables 
Variable Number Mean' 
Catheter s r i s  326 0.51 (kl.1) 
Hospital a missions 326 2.02 (23.2) 
Hospital days 326 18.1 (228.3) 
Emergency room visits 326 0.70 (11.4) 
Noncatheter infections 326 0.54 ('1.3) 
Catheter problems 326 1.33 (22.2) 
Tubing roblems 326 0.67 (21.2) 
326 1.43 (22.2) 
Pump, Ielivery, and sup ly problems 326 2.76 (22.7) 
326 2.82 (e3.4) 
Psychological/social issues 
Education/training/rein P orcement 
'Number in parenthesis is standard deviation. 
patient. Sixty-five percent of the patients were hos- 
pitalized at least once, for a wide variety of problems 
ranging from catheter sepsis to scheduled chemo- 
therapy. The range of hospital admissions per hos- 
pitalized patient extended from 1 to 21. The mean 
number of days per hospital episode was 18.1 (+28), 
with a range extending from 1 to 164. Thirty-four 
percent of the patients had at least one emergency 
room visit. The number of visits per patient ranged 
from 1 to 10, with a mean of 0.70 (21). Twenty-seven 
percent (n = 88) of the patients experienced a 
non-catheter infection, with some patients experi- 
encing repeated infections (up to 13 per patient). 
Very few of the patients had an adverse drug reac- 
tion (4.9%), which usually was associated with con- 
comitant antibiotic therapy. In contrast, 50% of the 
patients (n = 163) had reported catheter problems, 
such as exit site infection or resistance/sluggishness. 
Thirty-six percent (n = 117) of the subjects had 
reported tubing problems, primarily air in the tube 
or blood backup. 
Non-clinical problems were also reported by 
patients or their caregivers. Most patients receiving 
services from the home infusion provider were very 
satisfied with their care. Only 9% (n = 29) expressed 
any dissatisfaction, and the complaints were often 
directed at non-home infusion services, such as 
home health or laboratory services. A small percent- 
age (7%, 23 patients) expressed concerns about the 
costs of care or billing practices. In contrast, fully 
80% of the patients (n = 261) had at least one 
reported difficulty with their infusion pump, deliv- 
eries, or supplies. The mean number of reported 
problems with the pump, deliveries, or supplies was 
2.8 (23) per patient. In addition, 68% (n = 222) had 
knowledge deficits and received some type of addi- 
tional training or education via the telephone after 
discharge. The mean number of teaching interven- 
tions per patient was 2.8 (43). Fifty-three percent 
(n = 173) of the patients had psychosocial or eco- 
nomic issues that were associated with the treat- 
ment or their underlying disease process. Psychoso- 
cia1 problems were frequently related to caregiver 
stress, and patient stress, depression, or non-com- 
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Figure 4. Patient outcomes. 
pliance with therapy. Finally, symptoms were fre- 
quently experienced and reported by these patients 
or their caregivers, averaging 7.1 (29) symptoms 
per patient. 
Discussion 
The data contained in this database have multi- 
ple uses. These include benchmarking treatment 
processes and outcomes, identifying issues for qual- 
ity improvement projects, monitoring the effect of 
treatment process changes on patient outcomes, and 
monitoring changes in the demographics of the 
patients receiving services to identify emerging or 
changing needs. 
Benchmarking 
The database allows us to compare our out- 
comes with those reported in the literature by 
other centers, In the past, the OLEY Foundation 
collected data from multiple centers and reported 
these on an  annual basis. When comparing our 
overall hospitalization rate with previous OLEY 
reports, it appeared that our rate was higher 
than that achieved by other centers. Further 
analyses revealed, however, that  our database 
included a much higher percentage of patients 
with neoplasms, who frequently experienced 
scheduled admissions for chemotherapy. Once 
these hospital episodes were excluded from the 
analysis, our hospitalization rate fell into line 
with the other centers. The source of hospital 
data, however, does not allow easy separation of 
hospital admissions into the OLEY categories of 
primary diagnosis, new diagnosis, and treat- 
ment-related diagnosis. Additional comparisons 
can be made regarding longevity and mortality 
rates for selected populations. Identified differ- 
ences could lead to further explorations of possi- 
ble related factors, including differences in sever- 
ity of illness, selection criteria, or therapeutic 
approaches. 
Quality Improvement Projects 
Another useful application of the database is the 
ability to detect and then correct problems in service 
delivery. These are problems that interfere with the 
smooth delivery of clinical services and which do 
much to influence overall patient satisfaction and 
the cost of the provided services. Our data collection 
highlighted several areas where improvements were. 
needed. One major area for improvement was get- 
ting the right supplies in the right quantity to  the 
patients’ homes in a timely manner. A second focus 
had to be placed on the infusion pumps themselves, 
which had recurring problems with programming, 
power pack failure, alarms, rate control, and so on. 
Such an experience can be used to influence manu- 
facturers to improve their products, or face potential 
loss of a high-volume customer. The data can also be 
used to develop patient education programs for 
areas in which patients reported problems. 
Treatment Process Changes 
Having a database that now extends over a six- 
year period allows us to link changing practice 
patterns to the outcomes experienced by patients. 
Some of these changes have been driven by the 
reimbursement environment, and others by chang- 
December 2000 DATABASE FOR HOME PARENTERAL NUTRITION 285 
ing clinical practice patterns. Many changes in ther- 
apeutic approach have occurred during this time 
period. The electronic infusion devices were changed 
due to continued patient reports of problems. PICC 
lines became more popular than central venous 
catheters, as they were believed to be more cost- 
effective than traditional tunneled catheters. Dress- 
ing changes went from 3 or more days a week to once 
or twice a week. Training went from 12 hours on 
average in the inpatient setting before discharge, to 
4 to 6 hours, with training continued by the home 
health nurse. In rare instances, there was complete 
reliance on the home health nurses for training. At 
the same time, the average number of educational 
interventions postdischarge increased from 0.40 per 
patient in 1993 to 2.8 in 1995, and reached 5.1 in 
1997. The quicker discharges and reduced training 
hours before discharge were evident across all the 
payer groups. 
Having a comprehensive database allows us to 
analyze what impact, if any, these changes have had 
on selected patient outcomes. For example, we doc- 
umented a steady increase in the number of patient/ 
caregiver phone calls related to educational needs 
over the same time period as the decline in predis- 
charge training hours. We are currently examining 
whether one type of IV infusion catheter has fewer 
catheter-related problems compared with other 
types, and whether the occurrence of catheter prob- 
lems is related to changed catheter care routines or 
to other factors. 
Pafient Demographic Changes 
The characteristics of the patients being offered 
home infusion services has also been changing over 
time. A broader array of primary diagnoses is appar- 
ent, with HPN now being offered to patients with 
acute conditions (hyperemesis associated with preg- 
nancy) and to patients with non-traditional chronic 
conditions, such as cerebral palsy and Sickle Cell 
disease. Fewer patients are dying while actively 
receiving HPN, suggesting initiation of nutrition 
support earlier in the course of the disease or che- 
motherapy regimen. There also appears to be an 
expansion of the criteria used to select caregivers, 
moving from spouses and parents to more distant 
relatives and even non-relatives. Such changes have 
implications for the support that will be required to 
assure a successful home infusion therapy experi- 
ence. 
Special Projecfs 
The computerized database can also be used as a 
supplement to more focused studies. For example, a 
study comparing PICC line outcomes by source of 
insertion (IV team versus radiology) was conducted 
using preliminary data from the database, then 
supplemented by additional record review. Another 
study examined catheter sepsis rates in pediatric 
patients, again supplementing information con- 
tained in the database with additional data collec- 
tion. The availability of a comprehensive database 
makes such studies much more feasible, as it 
reduces the time required for data collection consid- 
erably. 
Conclusions 
The creation of a retrospective database for 
measuring the outcomes of home infusion ther- 
apy has enabled us to  compare our outcomes with 
other providers, monitor the impact of changes 
over time, and implement specific strategies to 
improve the quality of care delivery. It is a re- 
source for questions that are raised from partic- 
ipants involved with the care of these patients. It 
also raises questions that can be the focus of more 
controlled studies. The retrospective database 
also demonstrates the impact this therapy has on 
patient and family quality of life. Repeated hos- 
pitalizations, continuing symptomatology, coping 
with delivery, supply and pump problems, and 
experiencing complications of the underlying dis- 
ease and treatment process, all contribute to a 
lower quality of life for these individuals. Inter- 
ventions to avoid complications and subsequent 
hospitalizations, better manage symptoms, and 
reduce system-related problems would contribute 
to an improved quality of life for these patients. 
The retrospective database also has many limita- 
tions. First, it is constrained by the type of data that 
are routinely collected and recorded in medical 
records. The quality of the data is only as good as the 
quality of the documentation. There may be errors of 
omission and commission. Further, there is no infor- 
mation collected directly from the patient. Patient- 
based assessments (PBAs) would provide valuable 
outcome information from the patient’s perspective, 
including measures of functional status and well- 
being, patienufamily satisfaction with care and 
caregivers, caregiver preparation and support, and 
symptom management. A prospective data collec- 
tion process would allow collection of specific desired 
data elements from a wider variety of sources, 
including billing records and patient surveys. How- 
ever, such data collection is difficult because of the 
long-term nature of this type of therapy-requiring 
repeated measures, and because the probability of 
missing data are greater with the use of patient 
surveys. 
Outcomes studies have the potential to answer 
very important questions regarding the impact of 
medical, nursing, drug, and nutrition therapies on 
the costs of care, the quality of care, and the quality 
of life.13 This article has described one approach to 
outcomes analysis and some preliminary findings 
regarding the quality of care being delivered to home 
parenteral nutrition therapy patients in one setting. 
The data also offer a standard against which other 
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infusion groups can benchmark their clinical out- their implications for patient management. JPEN 15:384-393, 
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5. Smith CE. Quality of life in long-term TPN patients and their 
family caregivers. JPEN 17:501-506, 1993 
6. Her!indal ET, Bernstein LR, Wong AF, et  al. Complications of 
home parenteral nutrition. Clin Pharm 11:543-548, 1992 
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